Next Article in Journal
Impact of Water and Nutrient Supplementation on Yield of Prairie Plantings of Juneberry Amelanchier alnifolia Nutt., Cultivar and Windbreak Plantings
Next Article in Special Issue
Exploring the Bioprotective Potential of Halophilic Bacteria against Major Postharvest Fungal Pathogens of Citrus Fruit Penicillium digitatum and Penicillium italicum
Previous Article in Journal
Preliminary Assessment of Four Wild Leafy Species to Be Used as Baby Salads
Previous Article in Special Issue
First Report of Rose Bent Neck Caused by Sclerotinia sclerotiorum on Commercial Cut Roses (Rosa hybrida L.)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Phytochemical Constituents and Antimicrobial Activity of Euphorbia serrata L. Extracts for Borago officinalis L. Crop Protection

by
Eva Sánchez-Hernández
1,
Vicente González-García
2,
Ana Palacio-Bielsa
2,
José Casanova-Gascón
3,
Luis Manuel Navas-Gracia
1,
Jesús Martín-Gil
1 and
Pablo Martín-Ramos
1,*
1
Department of Agricultural and Forestry Engineering, ETSIIAA, Universidad de Valladolid, 34004 Palencia, Spain
2
Department of Agricultural, Forest and Environmental Systems, Agrifood Research and Technology Centre of Aragón, Instituto Agroalimentario de Aragón—IA2 (CITA-Universidad de Zaragoza), Avda. Montañana 930, 50059 Zaragoza, Spain
3
Instituto Agroalimentario de Aragón-IA2 (Universidad de Zaragoza-CITA), Avda. Montañana 930, 50059 Zaragoza, Spain
*
Author to whom correspondence should be addressed.
Horticulturae 2023, 9(6), 652; https://doi.org/10.3390/horticulturae9060652
Submission received: 8 May 2023 / Revised: 22 May 2023 / Accepted: 28 May 2023 / Published: 1 June 2023
(This article belongs to the Special Issue Plant Pathology in Horticultural Production)

Abstract

:
The Euphorbia genus is the third-largest group of blooming plants, features a rich morphological variability, has a near-cosmopolitan distribution, and diverse medicinal uses. Nonetheless, phytochemical information about Euphorbia serrata L. extracts is not available. The objective of this research was to examine the constituents of the hydromethanolic extract of its aerial parts and propose valorization pathways. The results of gas chromatography-mass spectroscopy (GC−MS) demonstrated that 3-methylbutyl formate, quinic acid, N1-(4-hydroxybutyl)-N3-methylguanidine acetate, and 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one were the main phytocompounds, which have antimicrobial activity. Such activity was assayed against Pseudomonas cichorii, Botrytis cinerea, Fusarium oxysporum, and Sclerotinia sclerotiorum, four of the most destructive diseases of borage (Borago officinalis L.) crops, obtaining minimum inhibitory concentrations (MICs) of 750 and 1000 μg·mL−1 against the bacterium and the three fungal taxa, respectively, in in vitro tests. Conjugation of the extract with chitosan oligomers (COS) enhanced this activity, leading to MIC values of 187.5, 750, 500, and 500 μg·mL−1 for P. cichorii, B. cinerea, F. oxysporum, and S. sclerotiorum, respectively. Additional in vivo assays against two of the pathogens confirmed the protective action of the COS–E. serrata extract conjugate complexes on artificially inoculated plants at a dose of 375 and 1000 μg·mL−1 for P. cichorii and F. oxysporum, respectively. These findings suggest that this plant species can be a rich source of biorationals for prospective use in crop protection.

Graphical Abstract

1. Introduction

Euphorbia serrata L. is an arvense, annual plant that grows up to 0.7 m tall (Figure S1). It is known as serrate spurge or sawtooth spurge because of the serrate shape of the border of its leaves. Like other members of the family Euphorbiaceae, it is considered toxic and poisonous [1] because it exudes skin irritant and inflammatory, white milky latex (a complex emulsion consisting of starches, sugars, proteins, alkaloids, oils, tannins, resins, and gums, in which the presence of ingenol-3-palmitate has been documented [2]) when its stems or leaves are broken. However, according to Alves et al. [3], its medicinal use is documented in the treatment of conditions such as bronchitis, asthma, skin ailments, parasitic infections of the intestines, migraines, warts, gonorrhea, and dysentery.
Reviews on this genus, such as those by Ernst et al. [4] and Jassbi [5], have emphasized the significance of investigating the therapeutic properties of Euphorbia species and their role as a natural product reservoir. For instance, phytochemical profiling of the leaves of Euphorbia hirta L. (employed in indigenous healing practices for diverse objectives, such as treating skin diseases, wounds, and rheumatism [6], and whose antimicrobial activity is supported by scientific evidence [7]) showed the presence of hydroxybenzoic and hydroxycinnamic acids, ethyl-gallic acid, digalloyl-quinic acid, feruloyl-coniferin, 5-O-caffeoyl-quinic acid trans isomer, protocatechuic acid-O-pentoside-O-hexoside, and di-, tri and tetra-O-galloyl-glucose isomers [8]. Various types of secondary metabolites including flavonoids, diterpenoids, triterpenoids, tannins, and lipids have been isolated and structurally characterized from Euphorbia helioscopia L., widely used in folk medicine in Turkey and China [9]. Yet, as far as the authors are aware, the composition of aerial parts of E. serrata has not been reported to date (only total phenolics and flavonoid contents are available [10], apart from the composition of its seeds [11]).
In light of the above, the aim of this study is two-fold: (i) to provide comprehensive information about E. serrata phytochemical composition and (ii) to explore prospective uses of its extracts. In particular, taking into consideration that phytochemicals present in other members of the family Euphorbiaceae have demonstrated strong activity against certain phytopathogens [12,13], its application to the control of plant diseases was investigated against four important pathogens of borage (Borago officinalis L.). The importance of this vegetable crop is increasing in Aragón (NE Spain) thanks to its promotion as part of avant-garde cookery in top-level restaurants, both in Spain and other countries. However, its production in the Ebro Valley is threatened by diseases like Fusarium wilt and root rot caused by Fusarium oxysporum Schltdl., which have been reported to destroy 70% of the crop in 2019 [14] and for which a control method has still not been found. Other two polyphagous pathogenic fungi, Botrytis cinerea Pers. (grey mold) and Sclerotinia sclerotiorum (Lib.) de Bary (cottony soft rot), either alone or in combination, also affect this specialty crop, particularly in open-air culture [15,16,17]. Concerning bacterial pathogens, Pseudomonas cichorii (Swingle 1925) Stapp 1928 [18] also poses a serious threat to borage, causing leaf spots, blight, and rotting, especially under high-humidity conditions such as those of glasshouse horticulture. Hence, the use of biorationals from E. serrata extracts to control these diseases would offer a natural-product-based approach to borage growers, meeting the specifications of Art. 14 of the European Directive 2009/128/EC, and may also find applicability in other vegetable crops also affected by these phytopathogens.

2. Material and Methods

2.1. Plant Samples and Reagents

Aerial parts from E. serrata plants were collected in May 2022 in the ‘Vía Verde del Canfranero’, near the city of Huesca, Spain (42°08′38.7″ N 0°26′54.0″ W), during the full blooming stage. Prof. J. Ascaso confirmed and validated a voucher specimen, which has been stored at the herbarium of the Escuela Politécnica Superior de Huesca, Universidad de Zaragoza. Samples from twenty specimens were combined to obtain representative composite samples, which were shade-dried, mechanically ground into powder, homogenized, and sieved through a 1 mm mesh.
Borage plants cv. “Movera” used in the in vivo experiments were supplied by Viveros Laraflor (Zaragoza, Spain).
Tryptic soy agar (TSA) and tryptic soy broth (TSB) were provided by Sigma–Aldrich Química (Madrid, Spain), while potato dextrose broth (PDB) and potato dextrose agar (PDA) were purchased from Becton Dickinson (Bergen County, NJ, USA). High-molecular-weight chitosan was procured from Hangzhou Simit Chem. and Tech. Co. (Hangzhou, China). NeutraseTM 0.8 L enzyme was acquired from Novozymes A/S (Bagsværd, Denmark).

2.2. Phytopathogens

Four P. cichorii bacterial strains (CITA Pci-2, CITA Pci-3, CITA Pci-4, and CITA Pci-5), obtained from diseased borage plants from the province of Zaragoza (Spain), were supplied by the Bacteriology Lab at the Center for Research and Agrifood Research and Technology Center of Aragón (Zaragoza, Spain) as subcultures on TSA. The fungal isolate of B. cinerea (CECT 20973) was obtained from the Spanish Type Culture Collection (CECT, Valencia, Spain). The fungal isolates of F. oxysporum (MYC-1593) (isolated from diseased borage plants) and S. sclerotiorum (MYC-799) were supplied by the Mycology Lab at the Center for Research and Agrifood Research and Technology Center of Aragón as subcultures on PDA.

2.3. Preparation of E. serrata Extract, Chitosan Oligomers, and Their Conjugate Complex

A dried aerial part sample (11.4 g) was combined with 90 mL of a methanol/water solution (1:17 v/v). The mixture was heated for 30 min at 50 °C, sonicated using a probe-type ultrasonicator (model UIP1000 hdT; Hielscher Ultrasonics; Teltow, Germany), and then centrifuged at 9000 rpm for 15 min. The resulting supernatant was filtered through Whatman No. 1 paper and subsequently subjected to freeze-drying to obtain the solid residue. The extraction yield was 52.6% (6 g). For subsequent gas chromatography-mass spectrophotometry (GC−MS) analysis, the freeze-dried extract was dissolved in HPLC-grade MeOH to obtain a 5 mg·mL−1 solution, followed by further filtration.
The method described in [19], with the modifications specified in [20], was followed to obtain chitosan oligomers (COS) with a molecular weight < 2000 Da in a solution with a pH of 4.5. COS and E. serrata extract solutions were mixed in a 1:1 (v/v) ratio (150 mL of each solution, at a concentration of 3000 μg·mL−1) and exposed to ultrasound for 15 min to form the conjugate complexes.

2.4. Physicochemical Characterization

A Thermo Scientific (Waltham, MA, USA) Nicolet iS50 Fourier-transform infrared (FTIR) spectrometer, with an in-built diamond attenuated total reflection (ATR) system, was used to register the infrared vibrational spectra of the shade-dried cyathia, shade-dried leaves, and latex samples. The spectral range of 400–4000 cm−1 was scanned with a 1 cm−1 resolution and 64 scans were co-added to generate the interferograms.
A gas chromatography-mass spectrometry (GC−MS) instrument comprising a model 7890A gas chromatograph coupled to a model 5975C quadrupole mass spectrometer (both from Agilent Technologies, Santa Clara, CA, USA) was used to elucidate the constituents of E. serrata aerial parts hydromethanolic extract. This analysis was outsourced to the Research Support Services (STI) at Universidad de Alicante (Alicante, Spain). The chromatographic conditions consisted of an injection volume of 1 µL, an injector temperature of 280 °C in splitless mode, an initial oven temperature of 60 °C held for 2 min, followed by a ramp of 10 °C·min−1 up to a final temperature of 300 °C held for 15 min. An HP-5MS UI chromatographic column (30 m length, 0.250 mm diameter, and 0.25 µm film), also from Agilent Technologies, was employed for the separation of the compounds. The mass spectrometer’s electron impact source and quadrupole temperatures were 230 and 150 °C, respectively, with an ionization energy of 70 eV. Components were identified through comparisons of mass spectra and retention times with those of authentic compounds and computer matching with the database of the National Institute of Standards and Technology (NIST11). Test mixture 2 for apolar capillary columns according to Grob (Supelco 86501) and PFTBA tuning standards were used for equipment calibration.

2.5. In Vitro Antimicrobial Activity Assessment

The antibacterial activity was assessed using the agar dilution method, according to the Clinical and Laboratory Standards Institute (CLSI) standard M07-11 [21]. Initially, P. cichorii colonies were incubated at 28 °C for 24 h in TSB. Subsequently, serial dilutions were performed, starting from a concentration of 108 CFU·mL−1, to achieve a final inoculum of 104 CFU·mL−1. Next, the bacterial suspension was spread on the surface of TSA plates to which the extract had been previously added, at concentrations ranging from 62.5 to 1500 μg·mL−1. The plates were then incubated at 28 °C for 24 h. The minimum inhibitory concentration (MIC) was determined as the lowest concentration of the extract at which no bacterial growth was visible. All experiments were replicated three times, with three plates per treatment and concentration.
The antifungal activity was determined using the agar dilution method as per the EUCAST antifungal susceptibility testing standard procedures [22]. Stock solution aliquots were incorporated into the PDA medium to produce final concentrations ranging from 62.5 to 1500 μg·mL−1. Mycelial plugs (⌀ = 5 mm), from the margin of 7-day-old PDA cultures of B. cinerea, S. sclerotiorum, and F. oxysporum were transferred to the center of PDA plates amended with the aforementioned concentrations (three plates per treatment and concentration, with two duplicates). Plates were incubated in the dark at 25 °C for seven days. The control consisted in replacing the extract with the solvent used for extraction (i.e., methanol:water 1:17 v/v) in the PDA medium. The inhibition of mycelial growth was estimated according to the formula in Equation (1):
((dcdt)/dc) × 100,
where dc and dt represent the mean diameters of the control and treated fungal colonies, respectively. The effective concentrations (EC50 and EC90) were determined via PROBIT analysis in SPSS Statistics v. 25 (IBM, New York, NY, USA). The synergy factor (SF), which measures the degree of interaction, was estimated using Wadley’s method [23].
Since the Shapiro–Wilk and Levene tests indicated that the homogeneity and homoscedasticity requirements were fulfilled, the mycelial growth inhibition results were subjected to one-way analysis of variance (ANOVA) and subsequent post hoc comparison of means through Tukey’s test at a significance level of p < 0.05 in IBM SPSS Statistics v. 25.

2.6. In Vivo Tests on Borage

Borage plants cv. “Movera” were used for in vivo experiments to assess the efficacy of the most potent in vitro treatment (i.e., COS–E. serrata) against artificially inoculated P. cichorii and F. oxysporum, following the methods described in [24] and [14], respectively, with minor modifications. Multiple 4 × 4 cm pots were used to grow the borage plants with sterile peat as substrate, with 5 plants per treatment and pathogen; two independent replicates were conducted. The treatment was applied at two concentrations (MIC and MIC × 2, i.e., 187.5 and 375 μg·mL−1 for P. cichorii, and 500 and 1000 μg·mL−1 for F. oxysporum). In the case of P. cichorii, it was applied through spraying (3 mL per plant). After 2 h, an isolated colony of P. cichorii was inoculated into the youngest leaflets by making 3–4 punctures using a sterile entomological pin. For the F. oxysporum assay, the fungus was previously grown in 250 mL flasks containing PDB for 3 days at 25 °C in the dark with constant shaking. Borage roots were then dipped in a suspension of 6 × 106 conidia·mL−1 for 2 min, and the plants were transferred to plastic pots with sterilized substrate. Non-inoculated plants sprayed with sterilized water or dipped in sterilized water were used as negative controls. All plants were incubated in a growth chamber (25 °C, 16/8 h photoperiod) for ten days.

3. Results

3.1. Infrared Spectra

The main absorption bands in the FTIR spectra (Figure S2) of E. serrata inflorescences (cyathia), leaves, and latex are listed in Table 1, alongside their functional group assignments. The symmetric C–H stretching vibrations of aliphatic groups (latex bands) are observed at 2916 ± 1 and 2848 ± 1 cm−1, while the C=O stretching band at 1730 ± 2 cm−1 indicates ester bonds and carboxylic acid groups. In the fingerprint region of the spectrum, C−H and O−H deformation vibrations characteristic of carbohydrates can be observed between 1200 and 1462 cm−1. Different types of C−H, C−O, and CH3 vibrations, which cannot be identified more precisely, appear in the lower range of the fingerprint region below 1200 cm−1 [25].
Since the functional groups were found to be similar in the three organs (cyathia, leaves, and latex), a combined sample was utilized for the rest of the study. This approach is advantageous from a practical standpoint as it obviates the necessity of separating the aerial plant organs for subsequent extraction.

3.2. GC−MS Characterization of the Extract

Among the fifty-three phytocompounds identified (Table 2, Figure 1 and Figure S3) in E. serrata aerial parts extract, the most abundant were: 1-butanol, 3-methyl-, formate (or 3-methylbutyl formate) (15.5%); quinic acid (14.4%), N1-(4-hydroxybutyl)-N3-methylguanidine acetate (5.3%), 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one (or DDMP) (4%), 2-amino-3-hydroxypyridine or 2-amino-3-pyridinol (3.9%), 4-oxohexenal (3.4%), ethyl methyl acetal acetone (3.2%), benzeneacetaldehyde (3.2%), squalene (2.7%), and hexadecanoic acid (1.9%). Among them, the assignments of (E)-4-oxohex-2-enal and ethyl methyl acetal acetone had quality of resemblance (Qual) values below 80, so their assignment is dubious.

3.3. In Vitro Antimicrobial Activity

3.3.1. In Vitro Antibacterial Activity

Some differences in terms of sensitivity to COS were observed among the four P. cichorii strains, with MIC values ranging from 500 to 750 µg·mL−1, as shown in Table 3. However, the MIC values obtained for E. serrata extract (comparable to/slightly higher than those of COS) and the COS–E. serrata conjugate complex (substantially lower than those of COS and E. serrata, with SF values > 1) were the same for all four strains.

3.3.2. In Vitro Antifungal Activity

Figure S4 summarizes the results of the antifungal capacity testing. Higher doses resulted in reduced radial mycelium growth for the three tested treatments (viz., COS, E. serrata extract, and COS–E. serrata extract conjugate complex), with statistically significant differences in the case of the three pathogens. COS fully inhibited the mycelial growth of B. cinerea and S. sclerotiorum at 1500 μg·mL−1 and that of F. oxysporum at 1000 μg·mL−1. Euphorbia serrata extract was more effective, resulting in complete inhibition of the three pathogens at 1000 μg·mL−1. However, the antifungal activity was substantially increased by the application of conjugate complexes: the COS−E. serrata conjugate complex led to full inhibition at doses between 500 and 750 μg·mL−1. Such activity enhancement was quantified using the effective concentration (EC) values of the separate bioactive products and those of the conjugate complexes (Table 4), obtaining the SF summarized in Table 5. Given that values close to two were obtained against the three phytopathogens, a clear synergistic action between COS and the extract may be inferred also in terms of antifungal activity.

3.4. In Vivo Antimicrobial Activity

3.4.1. In Vivo Antibacterial Activity against P. cichorii

Taking into consideration that the COS–E. serrata conjugate complex was shown to be the most active in the in vitro tests, its bacteriostatic activity was further tested in in vivo tests. It was applied as a preventive treatment against bacterial blight on borage plants cv. “Movera” (as shown in Figure 2). Ten days post-inoculation, positive control plants (inoculated with P. cichorii only) displayed necrotic lesions that covered the entire leaf (Figure 2b). Plants sprayed with the COS–E. serrata conjugate complex at a concentration equal to the MIC (187.5 µg·mL−1) had necrotic lesions in the area where the pathogen was inoculated, which did not spread to the entire leaf, but showed some discoloration around these necrotic spots (Figure 2c). In turn, plants treated with a dose twice the MIC (375 µg·mL−1) showed barely any signs of disease attack (as shown in Figure 2d). No symptoms were observed in mock-inoculated plants (sprayed with sterile distilled water) (Figure 2a).

3.4.2. In Vivo Antifungal Activity against F. oxysporum

Figure 3 shows the results of the in vivo assays conducted with COS–E. serrata conjugate complex on borage cv. “Movera” plants to assess the protective (fungistatic) activity against Fusarium wilt. All positive control plants showed the characteristic severe wilting and yellowing symptoms, accompanied by dry necrosis of the central veins of some leaves, followed by plant death (Figure 3b). The disease incidence among plants treated with the extract at a concentration equal to the MIC (500 μg·mL−1) was high (80%), but the disease severity was lower (Figure 3c). To achieve complete protection, the dose had to be increased to 1000 μg·mL−1: at twice the MIC, after which all plants remained asymptomatic (Figure 3d). It should be noted that at the highest concentration tested (1000 μg·mL−1), borage plants did not display symptoms of phytotoxicity, with no visual differences among plants treated at 1000 μg·mL−1 and the negative control (Figure 3a).

4. Discussion

4.1. On the Phytochemical Profile of the Extract

3-Methylbutyl formate is a wax monoester related to 2-methylbutyl esters found in Chamaemelum nobile (L.) All. It was previously identified in red raspberries [26]. Meanwhile, its analogs, 3-methybutyl acetate and 3-methylbutyl propionate, were identified in yeasts inhabiting Prunus avium (L.) L. and Prunus cerasus L. [27]. These volatile organic compounds have the potential for post-harvest disease management, and their emission is a predominant antifungal mechanism of antagonistic microorganisms. Ruiz-Moyano et al. [28] found that 2-methylbutyl acetate, produced by Hanseniaspora uvarum (Niehaus) Shehata, Mrak and Phaff ex M.T. Sm., effectively controlled the incidence of B. cinerea in strawberries and cherries. Additionally, 3-methylbutyl hexanoate and 3-methylbutyl pentanoate from Candida sake (Saito and Oda) van Uden and H.R. Buckley reduced the disease incidence of Penicillium expansum Link on apple fruits by 53% and the disease severity by 20% [29,30]. Thus, it is expected that 3-methylbutyl esters from E. serrata can induce intracellular ROS accumulation and inhibit mycelia growth and conidial sporulation, as demonstrated for other 3-methylbutyl esters against P. expansum, Curvularia lunata (Wakker) Boedijn, B. cinerea, and Alternaria alternata (Fr.) Keissl. [30].
Concerning quinic acid, this cyclohexanecarboxylic acid has been reported in the bark of Uncaria tomentosa (Willd. ex Schult.) DC. [31], as well as in the extracts of several parts of medicinal plants, including Achillea pseudoaleppica Hub.-Mor., Artemisia annua L., Coffea arabica L., Haematocarpus Validus (Miers) Bakh.fil. ex Forman, Hypericum empetrifolium Willd., Phagnalon saxatile (L.) Cass., Rumex nepalensis, and Ziziphus lotus L. [32]. Bai et al. [33] suggested that it could be used as an antibacterial agent in food preservation. The modulation of ribosome function, aminoacyl-tRNA synthesis, and alterations in the levels of glycerophospholipids and fatty acids, as well as interference with membrane fluidity by disrupting the oxidative phosphorylation pathway, are all significant contributors to its antibacterial effect [32]. Research on cellular functions has revealed that quinic acid leads to a notable decline in intracellular pH, lowers succinate dehydrogenase activity, and results in reduced intracellular ATP concentration. Lu et al. [34] indicated that the binding of quinic acid to RhlA, RhlR, and RhlB receptors interferes with the binding of signal molecules to these receptors, leading to the transcriptional regulation of signaling pathways.
1-(4-hydroxybutyl)-2-methylguanidine acetate is the main component of Eucalyptus grandis W.Hill ex Maiden leaves [35] and has also been identified in the fresh extract of Cucumis sativus L. [36] and in fiddleheads (fern fronds) [37]. Its origin may be related to the hydrolysis of crambescin A2 (the specific constituent of Crambe abyssinica Hochst. ex R.E.Fr.), demethylation of 3-ethyl-1-(2-ethyl-4-hydroxybutyl)guanidine, or deamination of L-arginine (Figure 4).
DDMP or 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one is a strong antioxidant in glucose–histidine Maillard reaction products [38]. It is also present in the extracts from Acalypha indica L., Ammannia baccifera L., Borassus flabellifer L., Camellia japonica L., Cocculus hirsutus (L.) Diels, C. sativus, Leucas aspera (Willd.) Link, Litchi chinensis Sonn., Marsilea quadrifolia L., Punica granatum L., Sambucus nigra L., and Rumex vesicarius L. [39,40,41]. Antibacterial activity has been demonstrated against Erwinia amylovora (Burrill 1882) Winslow et al., 1920) and Xylophilus ampelinus (Panagopoulos 1969) Willems et al., 1987 [39], and strong antifungal activity has been reported against Verticillium dahliae Kleb., Diaporthe amygdali (Delacr.) Udayanga, Crous and K.D. Hyde, and Phytophthora megasperma Drechsler [40].
2-amino-3-hydroxypyridine or 2-amino-3-pyridinol is a natural dye used for manufacturing hair colors, present in Petroselinum crispum (Mill) Fuss. and Coriandrum sativum L. [42]. It has been found biologically important in the preparation of clinical anti-inflammatory analgesics [43].
Benzeneacetaldehyde, previously identified in Armeria maritima (Mill.) Willd. flowers [44], has shown antibacterial activity [45].
Squalene is a triterpene with lipophilic properties and serves as a precursor to ergosterol, an important component of the plasmatic membrane in fungi and yeasts. Prior research has shown squalene to be a significant phytochemical in the bark of Quercus ilex subsp. ballota (Desf.) Samp. [46] and leaves of Hibiscus syriacus L. [47]. Furthermore, it is understood that squalene accumulation inside cells can lead to the formation of vesicles that contain squalene, thereby disrupting the fungal cell membrane. This process consequently removes essential membrane lipid components, weakening the fungal cells [48].
Hexadecanoic acid (or palmitic acid), found as the major component in A. maritima [44], has been shown to be highly suitable for the integrated control of phytopathogens [49].
Concerning the two constituents with dubious assignments (i.e., with low Qual values), 4-oxohexanal has not been previously identified in plants (only its analog 2-isopropyl-5-oxohexanal) [50]. It is a precursor of the gamma-lactone named 4-oxanolide, a metabolite produced by Saccharomyces cerevisiae (Desm.) Meyen. As for ethyl methyl acetal acetone (or 2-ethoxy-2-methoxypropane), it has not previously been reported in plant extracts either, but its derivative, 1-chloro-2-ethoxy-2-methoxy-propane has been reported from Ehretia laevis Roxb. [51] and Maytenus emarginata Willd. [52]. Hence, caution is advised as identification of these compounds is probably unreliable.
It is worth noting that no correspondence between the main phytochemicals reported above and the phytoconstituents reported for E. hirta leaves extract by Mekam et al. [8] was observed. This difference is tentatively ascribed to the different analytical methods employed (GC−MS vs. LC−ESI−IT−MS/MS).

4.2. On the Antimicrobial Activity in Comparison with Other Euphorbia spp. Extracts

Concerning previous reports on the antimicrobial activity of E. serrata, they are limited to human pathogens. Alghazeer et al. [10] found MIC values in the range of 3.13–6.25 mg·mL−1 against Staphylococcus aureus Rosenbach, 1884, methicillin-resistant S. aureus, Escherichia coli (Migula, 1895) Castellani and Chalmers, 1919, and Salmonella typhi (Schroeter, 1886) Warren and Scott, 1930 for methanolic extracts. According to Daud et al. [53], methanolic and chloroform extracts of E. serrata also inhibited the growth of Enterococcus faecalis (Andrewes and Horder, 1906), Schleifer and Kilpper-Bälz, 1984, Klebsiella pneumoniae (Schroeter, 1886) Trevisan, 1887, and Pseudomonas aeruginosa (Schroeter, 1872) Migula, 1900 (apart from those of S. aureus, E. coli, and S. typhi), but they did not report the MIC values.
With regard to the activity of other Euphorbia spp. extracts tested against human and plant pathogens, a summary of the efficacies reported in the literature is presented in Table 6. It should be noted that direct comparisons are not possible because the pathogens are different, and, in those cases in which the same species were tested, the strains were different. Furthermore, results were not expressed as EC or as MIC values in all studies. Consequently, the comparisons presented below should be interpreted as a first approximation. Focusing on the data reported against phytopathogens, the antibacterial activity of the non-conjugated E. serrata extract would be comparable to that of Euphorbia cotinifolia L. [54]. As for its antifungal activity, it would be substantially higher than those of E. hirta and Euphorbia tirucalli L. against F. oxysporum [8,55,56] and higher than those of Euphorbia guyoniana Boiss. and Reut. and Euphorbia royleana Boiss. against other Fusarium spp. [57,58], while it would be comparable to that of Euphorbia macroclada Boiss. (for which full inhibition of F. oxysporum was reported at 1000 μg·mL−1 for chloroform, petroleum ether, and butanol flower extracts, as well as for a chloroform stem extract) [59].

4.3. On the Efficacy of Other Natural Compounds against the Phytopathogens under Study

When comparing the efficacy of E. serrata extract against other plant extracts tested against the four phytopathogens considered here (Table S1) [24,44,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92,93,94,95,96,97,98,99,100,101,102], it may be observed that the MIC values (750 μg·mL−1 against P. cichorii and 1000 μg·mL−1 against the three fungal taxa) are among the lowest reported to date. The antibacterial activity against P. cichorii is the highest among the plant extracts presented in Table S1, comparable to that of Ginkgo biloba L. [24]. In the case of B. cinerea, the efficacy is only lower than those of U. tomentosa (375 μg·mL−1) [74], Cinnamomum cassia (L.) J.Presl, Syzygium aromaticum (L.) Merr. and Perry, and Origanum syriacum L. (600 μg·mL−1) [78,79,82], and it is comparable to that of Silene uniflora Roth (1000 μg·mL−1) [73]. Against F. oxysporum spp., the activity is lower than those of Cestrum nocturnum L. ethyl acetate and methanol extracts (500 μg·mL−1) [89] and A. maritima extract (750 μg·mL−1) [44], and it is comparable to that of Cestrum nocturnum hexane and chloroform extracts (1000 μg·mL−1) [89]. As for S. sclerotiorum, higher activities have only been reported for A. maritima (375 μg·mL−1) [44] and for some C. nocturnum extracts (250–1000 μg·mL−1) [89], and a comparable activity has been reported for Zingiber officinale Roscoe essential oil (1000 μg·mL−1) [100].

4.4. Comparison with Synthetic Fungicides

A comparison of the activity of three conventional synthetic fungicides against the three fungal taxa is presented in Table 7. In the case of B. cinerea and S. sclerotiorum, the same isolates were used, while a different F. oxysporum isolate was used. A comparison with five clinical-grade antibiotics against P. cichorii (strain CITA Pci-5) is summarized in Table S2.
With respect to the antifungal activity, the MIC values for E. serrata extract and the COS–E. serrata conjugate complex (1000 and 500–750 μg·mL−1, respectively) are lower than those of fosetyl-Al. Fosetyl-Al achieved full inhibition of B. cinerea and F. oxysporum at 2000 μg·mL−1, but it did not fully inhibit S. sclerotiorum at this concentration. Furthermore, the MIC values for E. serrata extract and the COS–E. serrata conjugate complex are much lower than those of azoxystrobin, which did not fully inhibit any of the fungal taxa at 62,500 μg·mL−1. However, the natural-based product would be less effective than mancozeb, for which full inhibition was achieved at 150 μg·mL−1 in all cases.
Regarding the antibacterial activity, E. serrata extract and the COS–E. serrata conjugate complex achieved full inhibition of P. cichorii strain CITA Pci-5 at 750 and 187.5 μg·mL−1 (Table 3). Therefore, at least the latter would be more active than ampicillin to which some Pseudomonas spp. are resistant due to their production of β-lactamases.

5. Conclusions

GC−MS characterization of the E. serrata hydromethanolic extract showed that the main constituents were 3-methylbutyl formate (15.5%), quinic acid (11.8%), N1-(4-hydroxybutyl)-N3-methylguanidine acetate (5.3%), and 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one (or DDMP) (4%). With a view to its valorization for borage crop protection, the antimicrobial activity of the extract was tested in vitro against four P. cichorii strains and three isolates of B. cinerea, F. oxysporum, and S. sclerotiorum, respectively. Minimum inhibitory concentrations of 750 and 1000 μg·mL−1 were obtained against the bacteria and the three fungal taxa, respectively. Upon conjugation of the extract with COS, the antimicrobial activity improved, resulting in MIC values of 187.5, 750, 500, and 500 μg·mL−1 for P. cichorii, B. cinerea, F. oxysporum, and S. sclerotiorum, respectively. The most active treatment (i.e., COS–E. serrata extract conjugate complex) was further tested in in vivo assays against the two pathogens that currently have a higher impact in the main growing areas of borage in Aragón (Spain), confirming a strong protective action at a dose of 375 and 1000 μg·mL−1 for P. cichorii and F. oxysporum, respectively. These findings are noteworthy since the plant extract showed higher activity than synthetic fungicides such as azoxystrobin and fosetyl-Al. Therefore, this study calls for further research on the applicability of E. serrata extract as a biorational in integrated pest management of borage and other horticultural crops.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/horticulturae9060652/s1, Figure S1: Euphorbia serrata aerial part and detail of the inflorescences (cyathia); Figure S2: Infrared spectra of E. serrata flowers, leaves, and latex; Figure S3: GC−MS chromatogram of E. serrata aerial parts hydromethanolic extract; Figure S4: Inhibition of the radial growth of the mycelium of B. cinerea, F. oxysporum, and S. sclerotiorum in the in vitro tests performed with PDA medium amended with different concentrations (in the range of 62.5–1500 µg·mL−1) of chitosan oligomers (COS), E. serrata aerial part extract, and their conjugate complex (COS–E. serrata). Table S1: Efficacy of plant extracts and essential oils reported in the literature against the phytopathogens under study; Table S2: Minimum inhibitory concentrations (expressed in μg∙mL−1) of conventional antibiotics (for clinical use) against P. cichorii strain CITA Pci-5.

Author Contributions

Conceptualization, V.G.-G. and A.P.-B.; methodology, J.C.-G. and A.P.-B.; validation, A.P.-B. and L.M.N.-G.; formal analysis, E.S.-H., J.C.-G. and P.M.-R.; investigation, E.S.-H., V.G.-G., A.P.-B., J.C.-G., L.M.N.-G., J.M.-G. and P.M.-R.; resources, A.P.-B. and L.M.N.-G.; writing—original draft preparation, E.S.-H., V.G.-G., A.P.-B., J.C.-G., L.M.N.-G., J.M.-G. and P.M.-R.; writing—review and editing, E.S.-H., V.G.-G. and P.M.-R.; visualization, E.S.-H.; supervision, P.M.-R. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the European Union through Horizon Program (HORIZON-CL6-2022-FARM2FORK-01) under project ‘Agro-ecological strategies for resilient farming in West Africa (CIRAWA)’, with project ID 101084398.

Data Availability Statement

The data presented in this study are available on request from the corresponding author.

Acknowledgments

The authors thank Pilar Blasco and Pablo Candela from the Technical Research Services of the University of Alicante for conducting the GC−MS analyses.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript or in the decision to publish the results.

References

  1. Lewis, R.J. Euphorbia serrata latex. In Sax’s Dangerous Properties of Industrial Materials, 11th ed.; John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2004; p. 1737. [Google Scholar] [CrossRef]
  2. Upadhyay, R.R.; Ansarin, M.; Zarintan, M.H.; Shakui, P. Tumor promoting constituent of Euphorbia serrata L. latex. Experientia 1976, 32, 1196–1197. [Google Scholar] [CrossRef] [PubMed]
  3. Alves, A.L.V.; da Silva, L.S.; Faleiros, C.A.; Silva, V.A.O.; Reis, R.M. The role of ingenane diterpenes in cancer therapy: From bioactive secondary compounds to small molecules. Nat. Prod. Commun. 2022, 17, 1–30. [Google Scholar] [CrossRef]
  4. Ernst, M.; Grace, O.M.; Saslis-Lagoudakis, C.H.; Nilsson, N.; Simonsen, H.T.; Rønsted, N. Global medicinal uses of Euphorbia L. (Euphorbiaceae). J. Ethnopharmacol. 2015, 176, 90–101. [Google Scholar] [CrossRef] [PubMed]
  5. Jassbi, A.R. Chemistry and biological activity of secondary metabolites in Euphorbia from Iran. Phytochemistry 2006, 67, 1977–1984. [Google Scholar] [CrossRef]
  6. Panzu, P.; Inkoto, C.; Ngbolua, K.; Mukeba, F.; Kitadi, J.M.; Taba, K.; Mbala, B.; Tshilanda, D.; Kayembe, J.P.K.; Pius Mpiana, T. Review on the phytochemistry, toxicology and bioactivities of Euphorbia hirta L.: A potential antisickling medicinal plant species. J. Med. Plant Herb. Ther. Res. 2020, 7, 8–18. [Google Scholar]
  7. Rajeh, M.A.B.; Zuraini, Z.; Sasidharan, S.; Latha, L.Y.; Amutha, S. Assessment of Euphorbia hirta L. leaf, flower, stem and root extracts for their antibacterial and antifungal activity and brine shrimp lethality. Molecules 2010, 15, 6008–6018. [Google Scholar] [CrossRef]
  8. Mekam, P.N.; Martini, S.; Nguefack, J.; Tagliazucchi, D.; Stefani, E. Phenolic compounds profile of water and ethanol extracts of Euphorbia hirta L. leaves showing antioxidant and antifungal properties. S. Afr. J. Bot. 2019, 127, 319–332. [Google Scholar] [CrossRef]
  9. Zhang, W.; Guo, Y.W. Chemical studies on the constituents of the chinese medicinal herb Euphorbia helioscopia L. Chem. Pharm. Bull 2006, 54, 1037–1039. [Google Scholar] [CrossRef]
  10. Alghazeer, R.; El-Saltani, H.; Saleh, N.; Al-Najjar, A.; Hebail, F. Antioxidant and antimicrobial properties of five medicinal Libyan plants extracts. Nat. Sci. 2012, 4, 324–335. [Google Scholar] [CrossRef]
  11. Azimova, S.S.; Glushenkova, A.I. Euphorbia serrata L. In Lipids, Lipophilic Components and Essential Oils from Plant Sources; Azimova, S.S., Glushenkova, A.I., Eds.; Springer: London, UK, 2012; p. 373. [Google Scholar] [CrossRef]
  12. Zahid, K. Evaluation of antifungal activity of nine members of family Euphorbiaceae of Lahore Region against Aspergillus niger, Rhizopus oryzae & Alternaria solani. Am. J. Biomed. Sci. Res. 2019, 6, 216–220. [Google Scholar] [CrossRef]
  13. Smaili, A.; Mazoir, N.; Rifai, L.A.; Koussa, T.; Makroum, K.; Benharref, A.; Faize, L.; Alburquerque, N.; Burgos, L.; Belfaiza, M.; et al. Antimicrobial activity of two semisynthetic triterpene derivatives from Euphorbia officinarum latex against fungal and bacterial phytopathogens. Nat. Prod. Commun. 2017, 12, 331–336. [Google Scholar] [CrossRef]
  14. González, V.; Aguado, A.; Garcés-Claver, A. First report of Fusarium oxysporum causing wilt and root rot in common borage (Borago officinalis) in Spain. Plant Dis. 2019, 103, 1774. [Google Scholar] [CrossRef]
  15. Bertetti, D.; Pensa, P.; Saracco, P.; Gullino, M.; Garibaldi, A. Recent disease observed on ornamental species bred in Liguria. Prot. Delle Colt. 2009, 2, 58–59. [Google Scholar]
  16. Garibaldi, A.; Pensa, P.; Bertetti, D.; Gullino, M.L. First report of white mold caused by Sclerotinia sclerotiorum on Borago officinalis in Italy. Plant Dis. 2008, 92, 1711. [Google Scholar] [CrossRef]
  17. Bradley, C.A.; del Río, L.E.; Chesrown, C.D.; Johnson, B.L. First report of soft rot caused by Sclerotinia sclerotiorum on borage in North Dakota. Plant Dis. 2005, 89, 208. [Google Scholar] [CrossRef]
  18. Cambra, M.A.; Palacio-Bielsa, A.; López, M.M. Borage (Borago officinalis) is a new host of Pseudomonas cichorii in the Ebro Valley of Spain. Plant Dis. 2004, 88, 769. [Google Scholar] [CrossRef]
  19. Santos-Moriano, P.; Fernandez-Arrojo, L.; Mengibar, M.; Belmonte-Reche, E.; Peñalver, P.; Acosta, F.; Ballesteros, A.; Morales, J.; Kidibule, P.; Fernandez-Lobato, M. Enzymatic production of fully deacetylated chitooligosaccharides and their neuroprotective and anti-inflammatory properties. Biocatal. Biotransform. 2018, 36, 57–67. [Google Scholar] [CrossRef]
  20. Ruano-Rosa, D.; Sánchez-Hernández, E.; Baquero-Foz, R.; Martín-Ramos, P.; Martín-Gil, J.; Torres-Sánchez, S.; Casanova-Gascón, J. Chitosan-based bioactive formulations for the control of powdery mildew in viticulture. Agronomy 2022, 12, 495. [Google Scholar] [CrossRef]
  21. CLSI Standard M07; Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. 11th ed. Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2018.
  22. Arendrup, M.C.; Cuenca-Estrella, M.; Lass-Flörl, C.; Hope, W.; EUCAST-AFST. EUCAST technical note on the EUCAST definitive document EDef 7.2: Method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST). Clin. Microbiol. Infect. 2012, 18, E246–E247. [Google Scholar] [CrossRef]
  23. Levy, Y.; Benderly, M.; Cohen, Y.; Gisi, U.; Bassand, D. The joint action of fungicides in mixtures: Comparison of two methods for synergy calculation. Bull. OEPP 1986, 16, 651–657. [Google Scholar] [CrossRef]
  24. Sánchez-Hernández, E.; González-García, V.; Palacio-Bielsa, A.; Lorenzo-Vidal, B.; Buzón-Durán, L.; Martín-Gil, J.; Martín-Ramos, P. Antibacterial activity of Ginkgo biloba extracts against Clavibacter michiganensis subsp. michiganensis, Pseudomonas spp., and Xanthomonas vesicatoria. Horticulturae 2023, 9, 461. [Google Scholar] [CrossRef]
  25. Günzler, H.; Gremlich, H.-U. IR-Spektroskopie: Eine Einführung, 4th ed.; John Wiley & Sons: Weinheim, Germany, 2012; p. 352. [Google Scholar]
  26. Klesk, K.; Qian, M.; Martin, R.R. Aroma extract dilution analysis of cv. Meeker (Rubus idaeus L.) red raspberries from Oregon and Washington. J. Agric. Food. Chem. 2004, 52, 5155–5161. [Google Scholar] [CrossRef] [PubMed]
  27. Mozūraitis, R.; Apšegaitė, V.; Radžiutė, S.; Aleknavičius, D.; Būdienė, J.; Stanevičienė, R.; Blažytė-Čereškienė, L.; Servienė, E.; Būda, V. Volatiles produced by yeasts related to Prunus avium and P. cerasus fruits and their potentials to modulate the behaviour of the pest Rhagoletis cerasi fruit flies. J. Fungi 2022, 8, 95. [Google Scholar] [CrossRef] [PubMed]
  28. Ruiz-Moyano, S.; Hernández, A.; Galvan, A.I.; Córdoba, M.G.; Casquete, R.; Serradilla, M.J.; Martín, A. Selection and application of antifungal VOCs-producing yeasts as biocontrol agents of grey mould in fruits. Food Microbiol. 2020, 92, 103556. [Google Scholar] [CrossRef]
  29. Zhao, X.; Zhou, J.; Tian, R.; Liu, Y. Microbial volatile organic compounds: Antifungal mechanisms, applications, and challenges. Front. Microbiol. 2022, 13, 922450. [Google Scholar] [CrossRef]
  30. Arrarte, E.; Garmendia, G.; Rossini, C.; Wisniewski, M.; Vero, S. Volatile organic compounds produced by Antarctic strains of Candida sake play a role in the control of postharvest pathogens of apples. Biol. Control 2017, 109, 14–20. [Google Scholar] [CrossRef]
  31. Åkesson, C.; Lindgren, H.; Pero, R.W.; Leanderson, T.; Ivars, F. Quinic acid is a biologically active component of the Uncaria tomentosa extract C-Med 100®. Int. Immunopharmacol. 2005, 5, 219–229. [Google Scholar] [CrossRef]
  32. Benali, T.; Bakrim, S.; Ghchime, R.; Benkhaira, N.; El Omari, N.; Balahbib, A.; Taha, D.; Zengin, G.; Hasan, M.M.; Bibi, S.; et al. Pharmacological insights into the multifaceted biological properties of quinic acid. Biotechnol. Genet. Eng. Rev. 2022, 1–30. [Google Scholar] [CrossRef]
  33. Bai, J.; Wu, Y.; Zhong, K.; Xiao, K.; Liu, L.; Huang, Y.; Wang, Z.; Gao, H. A comparative study on the effects of quinic acid and shikimic acid on cellular functions of Staphylococcus aureus. J. Food Prot. 2018, 81, 1187–1192. [Google Scholar] [CrossRef]
  34. Lu, L.; Zhao, Y.; Yi, G.; Li, M.; Liao, L.; Yang, C.; Cho, C.; Zhang, B.; Zhu, J.; Zou, K.; et al. Quinic acid: A potential antibiofilm agent against clinical resistant Pseudomonas aeruginosa. Chin. Med. 2021, 16, 72. [Google Scholar] [CrossRef]
  35. Peng, W.X.; Wu, F.J.; Wu, Y.Q.; Zhang, Z.F. Study on biomedical resources of benzene/alcohol extractives of Eucalyptus leaves by GC/MS. Adv. Mater. Res. 2010, 97–101, 2231–2236. [Google Scholar] [CrossRef]
  36. Budhiraja, H.; Gupta, R.K.; Nand, P. Formulation and characterization of Cucumis sativus extract in the treatment of acne. World J. Pharm. Pharm. Sci. 2014, 3, 1043–1057. [Google Scholar]
  37. Ma, Q.-Z.; Wu, F.-J.; Zhang, D.-Q.; Zhang, M.-L.; Liu, Q.-M. Study on risk management of investment on food and drug safety of fiddlehead. In Proceedings of the 2010 International Conference on Management and Service Science, Wuhan, China, 24–26 August 2010; pp. 1–4. [Google Scholar] [CrossRef]
  38. Yu, X.; Zhao, M.; Liu, F.; Zeng, S.; Hu, J. Identification of 2,3-dihydro-3,5-dihydroxy-6-methyl-4H-pyran-4-one as a strong antioxidant in glucose–histidine Maillard reaction products. Food Res. Int. 2013, 51, 397–403. [Google Scholar] [CrossRef]
  39. Sánchez-Hernández, E.; Buzón-Durán, L.; Cuchí-Oterino, J.A.; Martín-Gil, J.; Lorenzo-Vidal, B.; Martín-Ramos, P. Dwarf pomegranate (Punica granatum L. var. nana): Source of 5-HMF and bioactive compounds with applications in the protection of woody crops. Plants 2022, 11, 550. [Google Scholar] [CrossRef]
  40. Sánchez-Hernández, E.; Balduque-Gil, J.; González-García, V.; Barriuso-Vargas, J.J.; Casanova-Gascón, J.; Martín-Gil, J.; Martín-Ramos, P. Phytochemical profiling of Sambucus nigra L. flower and leaf extracts and their antimicrobial potential against almond tree pathogens. Int. J. Mol. Sci. 2023, 24, 1154. [Google Scholar] [CrossRef]
  41. Suman, T.Y.; Elumalai, D.; Kaleena, P.K.; Rajasree, S.R.R. GC−MS analysis of bioactive components and synthesis of silver nanoparticle using Ammannia baccifera aerial extract and its larvicidal activity against malaria and filariasis vectors. Ind. Crops Prod. 2013, 47, 239–245. [Google Scholar] [CrossRef]
  42. Thangavelu, S.; Balasubramanian, B.; Palanisamy, S.; Shanmugam, V.; Natchiappan, S.; Kalibulla, S.I.; Rathinasamy, B.; Arumugam, V.A. Characterization and phytoconstituents of Petroselinum crispum (Mill) and Coriandrum sativum (Linn) and their impacts on inflammation—An in vitro analysis against human adenocarcinoma cells with molecular docking. S. Afr. J. Bot. 2022, 146, 776–788. [Google Scholar] [CrossRef]
  43. Flouzat, C.; Bresson, Y.; Mattio, A.; Bonnet, J.; Guillaumet, G. Novel nonopioid non-antiinflammatory analgesics: 3-(aminoalkyl)-and 3-[(4-aryl-1-piperazinyl) alkyl] oxazolo [4, 5-b] pyridin-2 (3H)-ones. J. Med. Chem. 1993, 36, 497–503. [Google Scholar] [CrossRef]
  44. Sánchez-Hernández, E.; Martín-Ramos, P.; Navas Gracia, L.M.; Martín-Gil, J.; Garcés-Claver, A.; Flores-León, A.; González-García, V. Armeria maritima (Mill.) Willd. flower hydromethanolic extract for cucurbitaceae fungal diseases control. Molecules 2023, 28, 3730. [Google Scholar] [CrossRef]
  45. Manyi-Loh, C.E.; Ndip, R.N.; Clarke, A.M. Volatile compounds in honey: A review on their involvement in aroma, botanical origin determination and potential biomedical activities. Int. J. Mol. Sci. 2011, 12, 9514–9532. [Google Scholar] [CrossRef]
  46. Sánchez-Hernández, E.; Balduque-Gil, J.; Barriuso-Vargas, J.J.; Casanova-Gascón, J.; González-García, V.; Cuchí-Oterino, J.A.; Lorenzo-Vidal, B.; Martín-Gil, J.; Martín-Ramos, P. Holm oak (Quercus ilex subsp. ballota (Desf.) Samp.) bark aqueous ammonia extract for the control of invasive forest pathogens. Int. J. Mol. Sci. 2022, 23, 11882. [Google Scholar] [CrossRef] [PubMed]
  47. Sánchez-Hernández, E.; Buzón-Durán, L.; Lorenzo-Vidal, B.; Martín-Gil, J.; Martín-Ramos, P. Physicochemical characterization and antimicrobial activity against Erwinia amylovora, Erwinia vitivora, and Diplodia seriata of a light purple Hibiscus syriacus L. cultivar. Plants 2021, 10, 1876. [Google Scholar] [CrossRef] [PubMed]
  48. Ryder, N.S. Terbinafine: Mode of action and properties of the squalene epoxidase inhibition. Br. J. Dermatol. 1992, 126, 2–7. [Google Scholar] [CrossRef] [PubMed]
  49. Liu, S.; Ruan, W.; Li, J.; Xu, H.; Wang, J.; Gao, Y.; Wang, J. Biological control of phytopathogenic fungi by fatty acids. Mycopathologia 2008, 166, 93–102. [Google Scholar] [CrossRef]
  50. Jabbari, H.; Shendabadizad, R. GC−MS analysis of essential oils of Humulusn lupulus, Malva Sylvestris and thymus plants in water solvent. J. Adv. Pharm. Educ. Res. 2020, 10, 57. [Google Scholar]
  51. Sharma, P.; Shri, R.; Ntie-Kang, F.; Kumar, S. Phytochemical and ethnopharmacological perspectives of Ehretia laevis. Molecules 2021, 26, 3489. [Google Scholar] [CrossRef]
  52. Joshi, U.P.; Wagh, R.D. GC−MS analysis of phytochemical compounds present in the stembark extracts of plant Maytenus emarginata. Res. J. Pharm. Biol. Chem. Sci. 2019, 10, 159–165. [Google Scholar]
  53. Daud, M.; Sohail, S.; Nangyal, H.; Hidayatullah, M.M.; Akhtar, B.; Khattak, Z.F. Comparative in vitro study of Euphorbia cf Serrata stem extract against different pathogenic bacteria. Int. J. Biosci. 2014, 4, 182–186. [Google Scholar]
  54. Jayalakshmi, B.; Raveesha, K.; Amruthesh, K. Phytochemical analysis and antibacterial activity of Euphorbia cotinifolia Linn. leaf extracts against phytopathogenic bacteria. J. Pharm. Res. 2011, 4, 3759–3762. [Google Scholar]
  55. Shirazi, M.; Abid, M.; Hussain, F.; Abbas, A.; Sitara, U. Antifungal activity of some medicinal plant extracts against soil-borne phytopathogens. Pak. J. Bot. 2020, 52, 679–685. [Google Scholar] [CrossRef]
  56. Upadhyay, B.; Singh, K.; Kumar, A. Ethno-medicinal, phytochemical and antimicrobial studies of Euphorbia tirucalli L. J. Phytol. 2010, 2, 65–67. [Google Scholar]
  57. Salhi, N.; Mohammed Saghir, S.A.; Terzi, V.; Brahmi, I.; Ghedairi, N.; Bissati, S. Antifungal activity of aqueous extracts of some dominant Algerian medicinal plants. BioMed. Res. Int. 2017, 2017, 7526291. [Google Scholar] [CrossRef]
  58. Ashraf, A.; Sarfraz, R.A.; Rashid, M.A.; Shahid, M. Antioxidant, antimicrobial, antitumor, and cytotoxic activities of an important medicinal plant (Euphorbia royleana) from Pakistan. J. Food Drug Anal. 2015, 23, 109–115. [Google Scholar] [CrossRef]
  59. Al-Mughrabi, K. Antimicrobial activity of extracts from leaves, stems and flowers of Euphorbia macroclada against plant pathogenic fungi. Phytopathol. Mediterr. 2003, 42, 245–250. [Google Scholar]
  60. Kirbag, S.; Erecevit, P.; Zengin, F.; Guvenc, A.N. Antimicrobial activities of some Euphorbia species. Afr. J. Tradit. Complement. Altern. Med. 2013, 10, 305–309. [Google Scholar] [CrossRef]
  61. Kamba, A.; Hassan, L. Phytochemical screening and antimicrobial activities of Euphorbia balsamifera leaves, stems and root against some pathogenic microorganisms. Afr. J. Pharm. Pharmacol. 2010, 4, 645–652. [Google Scholar]
  62. Awaad, A.S.; Alothman, M.R.; Zain, Y.M.; Zain, G.M.; Alqasoumi, S.I.; Hassan, D.A. Comparative nutritional value and antimicrobial activities between three Euphorbia species growing in Saudi Arabia. Saudi Pharm. J. 2017, 25, 1226–1230. [Google Scholar] [CrossRef]
  63. Mohamed, S.; Saka, S.; El-Sharkawy, S.H.; Ali, A.M.; Muid, S. Antimycotic screening of 58 Malaysian plants against plant pathogens. Pestic. Sci. 1996, 47, 259–264. [Google Scholar] [CrossRef]
  64. Rao, K.V.B.; Karthik, L.; Elumalai, E.; Srinivasan, K.; Kumar, G. Antibacterial and antifungal activity of Euphorbia hirta l. leaves: A comparative study. J. Pharm. Res. 2010, 3, 548. [Google Scholar]
  65. Singh, G.; Kumar, P. Phytochemical study and screening for antimicrobial activity of flavonoids of Euphorbia hirta. Int. J. Appl. Basic Med. Res. 2013, 3, 111. [Google Scholar] [CrossRef]
  66. De Araújo, K.M.; De Lima, A.; do N. Silva, J.; Rodrigues, L.L.; Amorim, A.G.; Quelemes, P.V.; Dos Santos, R.C.; Rocha, J.A.; De Andrades, É.O.; Leite, J.R.S.; et al. Identification of phenolic compounds and evaluation of antioxidant and antimicrobial properties of Euphorbia tirucalli L. Antioxidants 2014, 3, 159–175. [Google Scholar] [CrossRef] [PubMed]
  67. Lin, J.; Dou, J.; Xu, J.; Aisa, H.A. Chemical composition, antimicrobial and antitumor activities of the essential oils and crude extracts of Euphorbia macrorrhiza. Molecules 2012, 17, 5030–5039. [Google Scholar] [CrossRef] [PubMed]
  68. Swamy, K.M.; Pokharen, N.; Dahal, S.; Anuradha, M. Phytochemical and antimicrobial studies of leaf extract of Euphorbia neriifolia. J. Med. Plants Res. 2011, 5, 5785–5788. [Google Scholar]
  69. Waheed, K.; Muhammad, S.K.; Shomaila, A.; Muhammad, Z.; Izhar, U.; Ullah, S. Antimicrobial activity and phytochemical screening of Euphorbia helioscopia. Planta Daninha 2020, 38, e020213727. [Google Scholar] [CrossRef]
  70. Behiry, S.I.; Okla, M.K.; Alamri, S.A.; El-Hefny, M.; Salem, M.Z.M.; Alaraidh, I.A.; Ali, H.M.; Al-Ghtani, S.M.; Monroy, J.C.; Salem, A.Z.M. Antifungal and antibacterial activities of wood treated with Musa paradisiaca L. peel extract: HPLC analysis of phenolic and flavonoid contents. Processes 2019, 7, 215. [Google Scholar] [CrossRef]
  71. El-Hefny, M.; Salem, M.Z.M.; Behiry, S.I.; Ali, H.M. The potential antibacterial and antifungal activities of wood treated with Withania somnifera fruit extract, and the phenolic, caffeine, and flavonoid composition of the extract according to HPLC. Processes 2020, 8, 113. [Google Scholar] [CrossRef]
  72. Delisle-Houde, M.; Tweddell, R.J.; Beres, B. Sugar maple autumn-shed leaf extract: A potential antibacterial agent for the management of lettuce bacterial leaf spot (Xanthomonas campestris pv. vitians) and varnish spot (Pseudomonas cichorii). Can. J. Plant Sci. 2020, 100, 78–85. [Google Scholar] [CrossRef]
  73. Buzón-Durán, L.; Sánchez-Hernández, E.; Martín-Ramos, P.; Navas-Gracia, L.M.; García-González, M.C.; Oliveira, R.; Martín-Gil, J. Silene uniflora extracts for strawberry postharvest protection. Plants 2023, 12, 1846. [Google Scholar] [CrossRef]
  74. Sánchez-Hernández, E.; Martín-Ramos, P.; Martín-Gil, J.; Santiago-Aliste, A.; Hernández-Navarro, S.; Oliveira, R.; González-García, V. Bark extract of Uncaria tomentosa L. for the control of strawberry phytopathogens. Horticulturae 2022, 8, 672. [Google Scholar] [CrossRef]
  75. Boiteux, J.; Espino, M.; de los Ángeles Fernández, M.; Pizzuolo, P.; Silva, M.F. Eco-friendly postharvest protection: Larrea cuneifolia-NADES extract against Botrytis cinerea. Rev. Fac. Cienc. Agrar. Univ. Nac. Cuyo 2019, 51, 427–437. [Google Scholar]
  76. Yusoff, S.F.; Haron, F.F.; Tengku Muda Mohamed, M.; Asib, N.; Sakimin, S.Z.; Abu Kassim, F.; Ismail, S.I. Antifungal activity and phytochemical screening of Vernonia amygdalina extract against Botrytis cinerea causing gray mold disease on tomato fruits. Biology 2020, 9, 286. [Google Scholar]
  77. Gwiazdowska, D.; Uwineza, P.A.; Frąk, S.; Juś, K.; Marchwińska, K.; Gwiazdowski, R.; Waśkiewicz, A. Antioxidant, antimicrobial and antibiofilm properties of Glechoma hederacea extracts obtained by supercritical fluid extraction, using different extraction conditions. Appl. Sci. 2022, 12, 3572. [Google Scholar] [CrossRef]
  78. Šernaitė, L.; Rasiukevičiūtė, N.; Valiuškaitė, A. Application of plant extracts to control postharvest gray mold and susceptibility of apple fruits to B. cinerea from different plant hosts. Foods 2020, 9, 1430. [Google Scholar] [CrossRef]
  79. Šernaitė, L.; Rasiukevičiūtė, N.; Dambrauskienė, E.; Viškelis, P.; Valiuškaitė, A. Biocontrol of strawberry pathogen Botrytis cinerea using plant extracts and essential oils. Zemdirbyste 2020, 107, 147–152. [Google Scholar] [CrossRef]
  80. Righini, H.; Baraldi, E.; García Fernández, Y.; Martel Quintana, A.; Roberti, R. Different antifungal activity of Anabaena sp., Ecklonia sp., and Jania sp. against Botrytis cinerea. Mar. Drugs 2019, 17, 299. [Google Scholar] [CrossRef]
  81. Şesan, T.E.; Enache, E.; Iacomi, B.M.; Oprea, M.; Oancea, F.; Iacomi, C. Antifungal activity of some plant extracts against Botrytis cinerea Pers. in the blackcurrant crop (Ribes nigrum L.). Acta Sci. Pol. Hortorum Cultus 2015, 14, 29–43. [Google Scholar]
  82. Abou-Jawdah, Y.; Wardan, R.; Sobh, H.; Salameh, A. Antifungal activities of extracts from selected lebanese wild plants against plant pathogenic fungi. Phytopathol. Mediterr. 2004, 43, 377–386. [Google Scholar]
  83. Salamone, A.; Zizzo, G.V.; Scarito, G. The antimicrobial activity of water extracts from Labiatae. Acta Hortic. 2006, 723, 465–470. [Google Scholar] [CrossRef]
  84. Minova, S.; Sešķēna, R.; Voitkāne, S.; Metla, Z.; Daugavietis, M.; Jankevica, L. Impact of pine (Pinus sylvestris L.) and spruce (Picea abies (L.) Karst.) bark extracts on important strawberry pathogens. Proc. Latv. Acad. Sci. B Nat. Exact Appl. Sci. 2015, 69, 62–67. [Google Scholar] [CrossRef]
  85. Onaran, A.; Bayan, Y. Antifungal activity of Liquidambar orientalis L., and Myrtus communis L. against some plant pathogenic fungi. Sci. Pap. Ser. A Agron. 2016, 59, 360–364. [Google Scholar]
  86. Méndez-Chávez, M.; Ledesma-Escobar, C.A.; Hidalgo-Morales, M.; Rodríguez-Jimenes, G.d.C.; Robles-Olvera, V.J. Antifungal activity screening of fractions from Annona cherimola Mill. leaf extract against Fusarium oxysporum. Arch. Microbiol. 2022, 204, 330. [Google Scholar] [CrossRef] [PubMed]
  87. Cherkupally, R.; Kota, S.R.; Amballa, H.; Reddy, B.N. In vitro antifungal potential of plant extracts against Fusarium oxysporum, Rhizoctonia solani and Macrophomina phaseolina. Ann. Plant Sci. 2017, 6, 1676. [Google Scholar] [CrossRef]
  88. Rongai, D.; Pulcini, P.; Pesce, B.; Milano, F. Antifungal activity of pomegranate peel extract against fusarium wilt of tomato. Eur. J. Plant Pathol. 2016, 147, 229–238. [Google Scholar] [CrossRef]
  89. Al-Reza, S.M.; Rahman, A.; Ahmed, Y.; Kang, S.C. Inhibition of plant pathogens in vitro and in vivo with essential oil and organic extracts of Cestrum nocturnum L. Pestic. Biochem. Physiol. 2010, 96, 86–92. [Google Scholar] [CrossRef]
  90. Chakma, M.; Bashar, M.A. In vitro control of Fusarium solani and F. oxysporum the causative agent of brinjal wilt. Dhaka Univ. J. Biol. Sci. 2014, 23, 53–60. [Google Scholar] [CrossRef]
  91. Jasso de Rodríguez, D.; Hernández-Castillo, D.; Angulo-Sánchez, J.L.; Rodríguez-García, R.; Villarreal Quintanilla, J.A.; Lira-Saldivar, R.H. Antifungal activity in vitro of Flourensia spp. extracts on Alternaria sp., Rhizoctonia solani, and Fusarium oxysporum. Ind. Crops Prod. 2007, 25, 111–116. [Google Scholar] [CrossRef]
  92. El-Mohamedy, R.S.R.; Abdalla, A.M. Evaluation of antifungal activity of Moringa oleifera extracts as natural fungicide against some plant pathogenic fungi in-vitro. Int. J. Agric. Technol. 2014, 10, 963–982. [Google Scholar]
  93. Chacón, C.; Bojórquez-Quintal, E.; Caamal-Chan, G.; Ruíz-Valdiviezo, V.M.; Montes-Molina, J.A.; Garrido-Ramírez, E.R.; Rojas-Abarca, L.M.; Ruiz-Lau, N. In vitro antifungal activity and chemical composition of Piper auritum Kunth essential oil against Fusarium oxysporum and Fusarium equiseti. Agronomy 2021, 11, 1098. [Google Scholar] [CrossRef]
  94. Satish, S.; Raghavendra, M.P.; Raveesha, K.A. Antifungal potentiality of some plant extracts against Fusarium sp. Arch. Phytopathol. Pflanzenschutz 2009, 42, 618–625. [Google Scholar] [CrossRef]
  95. Nelson, D.; Beattie, K.; McCollum, G.; Martin, T.; Sharma, S.; Rao, J.R. Performance of natural antagonists and commercial microbiocides towards in vitro suppression of flower bed soil-borne Fusarium oxysporum. Adv. Microbiol. 2014, 4, 151–159. [Google Scholar] [CrossRef]
  96. Al-Araji, A.M.Y.; Hasan, A.M.; Fradi, A.J.; Majeed, S.M.A.; Majeed, W.W.A.; Naji, E.T. Study of alkaloids, phenols and terpenes of Mentha spicata as a fungicide against Rhizoctonia solani, Sclerotinia sclerotiorum and Fusarium oxysporum. Int. J. Adv. Biol. Res. 2017, 7, 345–354. [Google Scholar]
  97. Singh, U.P.; Pathak, K.K.; Khare, M.N.; Singh, R.B. Effect of leaf extract of garlic on Fusarium oxysporum f. sp. ciceri, Sclerotinia sclerotiorum and on gram seeds. Mycologia 2018, 71, 556–564. [Google Scholar] [CrossRef]
  98. Ahmed, G.; Elsisi, A. Efficacy of compost and some essential oils alone or in combination in controlling cucumber white mould disease under protected house conditions. J. Plant Prot. Pathol. 2020, 11, 291–297. [Google Scholar] [CrossRef]
  99. Elbatawy, Y.M.; Mohamed, F.G.; Eisa, N.A.; El-Habbak, M.H. Evaluation of some biological agents and plant extracts for controlling cucumber white rot caused by Sclerotinia sclerotiorum (Lib) de Bary. Ann. Agric. Sci. Moshtohor 2020, 58, 351–364. [Google Scholar] [CrossRef]
  100. Hussein, K.A. Antifungal activity and chemical composition of ginger essential oil against ginseng pathogenic fungi. Curr. Res. Environ. Appl. Mycol. 2018, 8, 194–203. [Google Scholar] [CrossRef]
  101. Onaran, A.; Yılar, M. Antifungal and herbicidal activity of Trachystemon orientalis (L.) G. Don against some plant pathogenic fungi and Cuscuta campestris Yunck. Iğdır Univ. J. Inst. Sci. Tech. 2018, 8, 37–43. [Google Scholar]
  102. Goussous, S.J.; Mas’ad, I.S.; Abu El-Samen, F.M.; Tahhan, R.A. In vitro inhibitory effects of rosemary and sage extracts on mycelial growth and sclerotial formation and germination of Sclerotinia sclerotiorum. Arch. Phytopathol. Pflanzenschutz 2013, 46, 890–902. [Google Scholar] [CrossRef]
Figure 1. Main phytochemicals identified in Euphorbia serrata extract.
Figure 1. Main phytochemicals identified in Euphorbia serrata extract.
Horticulturae 09 00652 g001
Figure 2. Symptoms of bacterial blight in borage plants ten days post-inoculation in (a) negative control plants; (b) positive control plants; (c) plants sprayed with COS–E. serrata conjugate complex at 187.5 μg∙mL−1; and (d) plants sprayed with COS–E. serrata conjugate complex at 375 μg∙mL−1.
Figure 2. Symptoms of bacterial blight in borage plants ten days post-inoculation in (a) negative control plants; (b) positive control plants; (c) plants sprayed with COS–E. serrata conjugate complex at 187.5 μg∙mL−1; and (d) plants sprayed with COS–E. serrata conjugate complex at 375 μg∙mL−1.
Horticulturae 09 00652 g002
Figure 3. Symptoms of wilt, stem, and root rot produced by F. oxysporum in borage plants ten days post-inoculation in (a) negative control plants; (b) positive control plants; (c) plants treated with COS–E. serrata conjugate complex at 500 μg∙mL−1; and (d) plants treated with COS–E. serrata conjugate complex at 1000 μg∙mL−1.
Figure 3. Symptoms of wilt, stem, and root rot produced by F. oxysporum in borage plants ten days post-inoculation in (a) negative control plants; (b) positive control plants; (c) plants treated with COS–E. serrata conjugate complex at 500 μg∙mL−1; and (d) plants treated with COS–E. serrata conjugate complex at 1000 μg∙mL−1.
Horticulturae 09 00652 g003
Figure 4. (top) 1-(4-hydroxybutyl)-2-methylguanidine precursors: crambescin A and 3-ethyl-1-(2-ethyl-4-hydroxybutyl)guanidine; (bottom) Scheme on the deamination of L-arginine.
Figure 4. (top) 1-(4-hydroxybutyl)-2-methylguanidine precursors: crambescin A and 3-ethyl-1-(2-ethyl-4-hydroxybutyl)guanidine; (bottom) Scheme on the deamination of L-arginine.
Horticulturae 09 00652 g004
Table 1. Main absorption bands in the FTIR spectra of Euphorbia serrata plant organs and latex.
Table 1. Main absorption bands in the FTIR spectra of Euphorbia serrata plant organs and latex.
FlowersLeavesLatexAssignment
330032973355Bonded O–H stretching (cellulose, hemicellulose, lignin)
291729162916–CH2 asymmetric stretching of alkyls (cutine, wax, pectin)
284928482848–CH2 symmetric stretching (cutine and wax); CH2–(C6)–bending (cellulose)
173217321728C=O from esters
163516351646C=O stretching of alkyl ester
1598 phenyl ring (aromatic skeletal vibration)
14721472methyl C–H asymmetrical
146214621463scissoring mode of –CH in CH2
141614161417(CH)C=CH2 in plane scissoring
136213751374C-C asymmetrical stretching phenolic hydroxyl groups
131113151312C–H in-plane bending
124312451243C–O stretching; amide N–H vibration
117011691167C–O–C asymmetric stretching in cellulose; C–C in-plane
110311011103C–O–C stretching in the pyranose skeletal ring
105010621050stretching mode of C–O bond
101910191019C–H bending; C–C stretching
959961C–H out-of-plane bending
719719719CH2 rocking vibrations
Table 2. Main phytoconstituents identified by GC−MS in Euphorbia serrata aerial parts extract.
Table 2. Main phytoconstituents identified by GC−MS in Euphorbia serrata aerial parts extract.
RT (min)Area (%)Assignment
4.27671.88521,3-Dihydroxyacetone dimer
4.35391.2792Dihydroxyacetone
4.58530.8633Butyrolactone
4.66250.9757Formic acid, pentyl ester
4.73371.17852-Cyclopenten-1-one, 2-hydroxy-
5.06020.75572H-Pyran-2-one
5.55280.72912,4-Dihydroxy-2,5-dimethyl-3(2H)-furan-3-one
5.73081.3414Formic acid, 2-propenyl ester
5.79020.7461Cyclopropanecarboxamide
5.86143.3739(E)-4-Oxohex-2-enal
6.46090.6257Guanazine
6.54993.1997Benzeneacetaldehyde
6.7280.82161,3-Dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone
7.33931.02342-Heptanamine, 5-methyl-
7.523315.45751-Butanol, 3-methyl, formate
7.95661.2667Ethanamine, N-ethyl-N-nitroso-
8.08713.97114H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl-
8.38980.75662(3H)-Furanone, dihydro-4-hydroxy-
8.47891.0122Bicyclo[4.2.0]octa-1,3,5-triene, 7-(2-propenyl)-
8.91811.7303Catechol
9.04871.63843-(α-Hydroxyethyl)-aniline
9.16741.22Benzofuran, 2,3-dihydro-
9.35730.58295-Hydroxymethylfurfural
9.58880.6945Butanoic acid, 3-oxo-, hexyl ester
9.83810.96021,2-Benzenediol, 3-methoxy-
10.06360.4961Hydroquinone
10.16450.5023Isosorbide
10.22391.32332-Butanone, 4-hydroxy-3-methyl-
10.55621.52942-Methoxy-4-vinylphenol
11.47620.38761,4-Hexadiene, 2,3,4,5-tetramethyl-
11.65430.4644N,N-Diethylaniline
11.86790.29276-Methylthiocarbonyl-2,4-diamino-6,7-dihydro-5H-pyrrolo[3,4-d]pyrimidin
12.46155.2679N1-(4-hydroxybutyl)-N3-methylguanidine acetate
12.48523.2235Acetone, ethyl methyl acetal
12.82350.8293Ethanone, 1-(3-hydroxy-4-methoxyphenyl)-
12.85911.065Adamantane
13.04911.0355Buformin
13.17371.17522-Hydroxy-1-(1′-pyrrolidiyl)-1-buten-3-one
13.95720.22783-Methyl-4-phenyl-1H-pyrrole
14.414211.7827(1R,3R,4R,5R)-(-)-Quinic acid
15.88023.93412-Amino-3-hydroxypyridine
16.02860.7147d-Proline, N-allyloxycarbonyl-, allyl ester
16.9071.3827Tetradecanoic acid
17.58960.5213Hexadecanoic acid, methyl ester
17.72020.61459-Hexadecenoic acid
17.9161.9156n-Hexadecanoic acid
19.28110.593Methyl 6,9,12-hexadecatrienoate
19.49480.1775Heptadecanoic acid, 16-methyl-, methyl ester
19.58980.46769-Octadecenoic acid, (E)-
19.78560.3783Octadecanoic acid
25.09182.7381Squalene
25.52511.7309n-Tetracosanol-1
30.92031.7537N-Methyl-1-adamantaneacetamide
Table 3. Minimum inhibitory concentrations (in µg·mL−1) against four P. cichorii strains of chitosan oligomers (COS) and E. serrata aerial part extract alone, and their conjugate complex (COS–E. serrata). Synergy factors (SF) calculated for the conjugate complex are also indicated.
Table 3. Minimum inhibitory concentrations (in µg·mL−1) against four P. cichorii strains of chitosan oligomers (COS) and E. serrata aerial part extract alone, and their conjugate complex (COS–E. serrata). Synergy factors (SF) calculated for the conjugate complex are also indicated.
BacteriaStrainCOSE. serrataCOS–E. serrataSF
P. cichoriiPci-2750750187.54.00
Pci-3750750187.54.00
Pci-4500750187.53.20
Pci-5500750187.53.20
Table 4. Effective concentrations (EC, in µg·mL−1) against B. cinerea, F. oxysporum, and S. sclerotiorum of chitosan oligomers (COS) and E. serrata aerial part extract alone, and their conjugate complex (COS–E. serrata).
Table 4. Effective concentrations (EC, in µg·mL−1) against B. cinerea, F. oxysporum, and S. sclerotiorum of chitosan oligomers (COS) and E. serrata aerial part extract alone, and their conjugate complex (COS–E. serrata).
TreatmentECB. cinereaF. oxysporumS. sclerotiorum
COSEC50236.2233.2864.3
EC901426.3743.41344.8
E. serrataEC50402.2402.1408.7
EC90832.4796.2673.4
COS–E. serrataEC50140.0142.4282.0
EC90500.6378.4363.7
Table 5. Synergy factors for the COS–E. serrata conjugate complex.
Table 5. Synergy factors for the COS–E. serrata conjugate complex.
TreatmentECB. cinereaF. oxysporumS. sclerotiorum
COS–E. serrataEC502.132.071.97
EC902.102.032.47
Table 6. Inhibition values reported in the literature for Euphorbia spp. extracts against various microorganisms.
Table 6. Inhibition values reported in the literature for Euphorbia spp. extracts against various microorganisms.
Euphorbia spp.Extraction MediumPathogensEfficacyRef.
E. guyonianawater (20%)Fusarium graminearum
Fusarium sporotrichioides
IZ = 27.3–47.85 mm[57]
E. cotinifoliaethyl acetate and methanolXanthomonas axonopodis pv. malvacearum
Xanthomonas axonopodis pv. vesicatoria
Xanthomonas oryzae
Agrobacterium tumefaciens
Xanthomonas campestris pv. campestris
Pectobacterium carotovorum subsp. carotovorum
Pseudomonas solanacearum
Pseudomonas syringae
MIC = 300–1300 μg·mL−1[54]
E. royleanamethanol, hexane, and water
(800 μg·mL−1)
Escherichia coli
Bacillus subtilis
Pasteurella multocida
Aspergillus niger
Fusarium solani
IZ = 5.7–14.0 mm[58]
E. macrocladabutanol, chloroform, petroleum ether, and water extracts of flowers, stems, and leaves
(1000 μg·mL−1)
Fusarium oxysporum
Rhizoctonia solani
Pythium sp.
Verticillium dahliae
Alternaria solani
Stemphylium solani
Rhizopus stolonifer
Penicillium italicum
Cladosporium sp.
Mucor sp.
IR = 0.1–89.9% (pooled avg.) for flower extracts; 7–81.3% for stem extracts; 0–8.1% for leaf extracts[59]
E. aleppica
E. szovitsii
E. falcata
E. denticulata
E. macroclada
E. cheiradenia
E. virgata
E. petiolata
methanolStaphylococcus aureus
Bacillus megaterium
Proteus vulgaris
Klebsiella pneumoniae
E. coli
Pseudomonas aeruginosa
Candida albicans
Candida glabrata
Candida tropicalis
Trichophyton sp.
Epidermophyton sp.
IZ = n.a.–25 mm[60]
E. balsamiferaethanol, petroleum ether, chloroform, and waterSalmonella typhimurium
P. aeruginosa
Klebsiella spp.
E. coli
C. albicans
MIC = 5000–6000 μg·mL−1
MBC = 4500–6000 μg·mL−1
[61]
E. granulata
E. helioscopia
E. hirta
ethanolE. coli
K. pneumoniae
P. vulgaris
S. aureus
Staphylococcus epidermidis
Streptococcus pyogenes
Aspergillus fumigatus
C. albicans
C. tropicalis
Geotrichum candidum
Microsporum canis
Trichophyton mentagrophytes
MIC = 3.90–250 μg·mL−1 for Gram-negative bacteria; 1.95–15.62 μg·mL−1 for Gram-positive bacteria; 1.95–500 μg·mL−1 for fungi[62]
E. hirta
E. tirucalli
ethanol
(concentration not available)
Colletotrichum capsicii
Fusarium pallidoroseum
Botryodiplodia theobromae
Alternaria alternata
Penicillium citrinum
Phomopsis caricae-papayae
A. niger
IZ = n.a.–9 mm[63]
E. hirtaethanol and waterFusarium oxysporum f. sp. vasinfectum
A. solani
R. solani
IC50 = 2930–32,140 μg·mL−1[8]
water (5%)R. solani
F. oxysporum
Macrophomina phaseolina
IR = 10–80%[55]
ethanol (concentration not available)S. aureus
Bacillus cereus
Salmonella typhi
K. pneumoniae
P. aeruginosa
A. niger
A. fumigatus
Aspergillus flavus
Rhizopus oryzae
IZ = n.a.–13.90 mm[64]
methanolS. aureus
Bacillus thuringiensis
B. subtilis
Micrococcus sp.
E. coli
K. pneumoniae
Proteus mirabilis
S. typhi
C. albicans
IZ = n.a.–29 mm, at 100,000 μg·mL−1
MIC = 3130–100,000 μg·mL−1
MBC/MFC = 3130–100,000 μg·mL−1
[7]
methanol, petroleum ether, ethyl ether, and ethyl acetateE. coli
P. aeruginosa
P. mirabilis
S. aureus
A. flavus
A. niger
T. mentagrophytes
C. albicans
MIC = n.a.–625 μg·mL−1
MBC/MFC = n.a.–1250 μg·mL−1
[65]
E. tirucalliacetone, methanol, and waterS. aureus
S. epidermidis
Enterococcus faecalis
E. coli
P. aeruginosa
IZ = n.a.–16 mm, at 10,000 μg·mL−1
MIC = n.a.–400 μg·mL−1
[66]
methanolE. coli
P. vulgaris
Salmonella enteritidis
B. subtilis
S. aureus
P. aeruginosa
K. pneumoniae,
C. albicans
C. tropicalis
A. niger
A. fumigatus
A. flavus
F. oxysporum
IZ = 1–21.5 mm, at 7500 μg·mL−1
MIC = n.a.–>1000 μg·mL−1
[56]
E. macrorrhizabutanol, chloroform, ethyl acetate, methanol, hexaneS. aureus
E. coli
C. albicans
MIC = 500–>2000 μg·mL−1
MBC/MFC = 1000–>2000 μg·mL−1
[67]
E. neriifoliabutanol, chloroform, ethyl acetate, ethanol, and water (50 μg·mL−1)S. aureus
K. pneumoniae
E. coli
P. vulgaris
Pseudomonas fluorescens
IZ = n.a.–8 mm[68]
E. helioscopiaethanol and water
(1000 μg·mL−1)
Trichoderma harzianum
Rhizopus nigricans
A. niger
IZ = 32–33 mm
IZ = 22–32 mm
IZ = 24–34 mm
[69]
IZ: inhibition zone; MIC: minimum inhibitory concentration; IR: inhibition rate; MBC: Minimum Bactericidal Concentration; IC50: half-maximal inhibitory concentration; MFC: minimum fungicidal concentration; n.a.: no activity.
Table 7. Radial growth of mycelium of B. cinerea, F. oxysporum, and S. sclerotiorum in in vitro experiments using a PDA medium modified with varying concentrations (the recommended dose, 1/10th of the recommended dose, and 10 times the recommended dose) of three synthetic fungicides.
Table 7. Radial growth of mycelium of B. cinerea, F. oxysporum, and S. sclerotiorum in in vitro experiments using a PDA medium modified with varying concentrations (the recommended dose, 1/10th of the recommended dose, and 10 times the recommended dose) of three synthetic fungicides.
Commercial
Fungicide
PathogenMycelium Radial Growth (mm)Inhibition (%)Ref.
ControlRd/10Rd *Rd/10Rd *
AzoxystrobinB. cinerea75.012518432[74]
F. oxysporum spp.75.045.040.040.046.7[44]
S. sclerotiorum75.014.09.081.388.0
MancozebB. cinerea75.000100100[74]
F. oxysporum spp.75.00.00.0100.0100.0[44]
S. sclerotiorum75.00.00.0100.0100.0
Fosetyl-AlB. cinerea75.038049.3100[74]
F. oxysporum spp.75.066.70.011.1100.0[44]
S. sclerotiorum75.075.013.30.082.2
* Rd stands for the recommended dose, i.e., 62.5 mg·mL−1 of azoxystrobin (250 g·L−1 for Ortiva®, azoxystrobin 25%), 1.5 mg·mL−1 of mancozeb (2 g·L−1 for Vondozeb®, mancozeb 75%), and 2 mg·mL−1 of fosetyl-Al (2.5 g·L−1 for Fosbel®, fosetyl-Al 80%). The radial growth of the mycelium for the control (PDA) was 75 mm. All mycelial growth values (in mm) are average values (n = 3).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sánchez-Hernández, E.; González-García, V.; Palacio-Bielsa, A.; Casanova-Gascón, J.; Navas-Gracia, L.M.; Martín-Gil, J.; Martín-Ramos, P. Phytochemical Constituents and Antimicrobial Activity of Euphorbia serrata L. Extracts for Borago officinalis L. Crop Protection. Horticulturae 2023, 9, 652. https://doi.org/10.3390/horticulturae9060652

AMA Style

Sánchez-Hernández E, González-García V, Palacio-Bielsa A, Casanova-Gascón J, Navas-Gracia LM, Martín-Gil J, Martín-Ramos P. Phytochemical Constituents and Antimicrobial Activity of Euphorbia serrata L. Extracts for Borago officinalis L. Crop Protection. Horticulturae. 2023; 9(6):652. https://doi.org/10.3390/horticulturae9060652

Chicago/Turabian Style

Sánchez-Hernández, Eva, Vicente González-García, Ana Palacio-Bielsa, José Casanova-Gascón, Luis Manuel Navas-Gracia, Jesús Martín-Gil, and Pablo Martín-Ramos. 2023. "Phytochemical Constituents and Antimicrobial Activity of Euphorbia serrata L. Extracts for Borago officinalis L. Crop Protection" Horticulturae 9, no. 6: 652. https://doi.org/10.3390/horticulturae9060652

APA Style

Sánchez-Hernández, E., González-García, V., Palacio-Bielsa, A., Casanova-Gascón, J., Navas-Gracia, L. M., Martín-Gil, J., & Martín-Ramos, P. (2023). Phytochemical Constituents and Antimicrobial Activity of Euphorbia serrata L. Extracts for Borago officinalis L. Crop Protection. Horticulturae, 9(6), 652. https://doi.org/10.3390/horticulturae9060652

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop